Scarica l'app Stockscreener
8.91
3.99%
-0.37
Dopo l'orario di chiusura:
8.61
-0.30
-3.37%
Panoramica
Notizia
Cronologia dei prezzi
Catena di opzioni
Financials
Perché ALGS Giù?
Forum
Previsione
Precedente Chiudi:
$9.28
Aprire:
$8.95
Volume 24 ore:
38,504
Relative Volume:
0.31
Capitalizzazione di mercato:
$47.35M
Reddito:
$7.97M
Utile/perdita netta:
$-75.74M
Rapporto P/E:
-0.3669
EPS:
-24.2853
Flusso di cassa netto:
$-85.33M
1 W Prestazione:
-1.44%
1M Prestazione:
+8.13%
6M Prestazione:
-70.72%
1 anno Prestazione:
-33.88%
Intervallo 1D:
$8.672
$9.1108
Intervallo di 1 settimana:
$8.18
$9.92
Portata 52W:
$3.76
$46.80
Aligos Therapeutics Inc Stock (ALGS) Company Profile
Nome
Aligos Therapeutics Inc
Settore
Industria
Telefono
(800) 466-6059
Indirizzo
ONE CORPORATE DR., 2ND FLOOR, SOUTH SAN FRANCISCO
Confronta ALGS con altri titoli
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
ALGS
Aligos Therapeutics Inc
|
8.91 | 56.75M | 7.97M | -75.74M | -85.33M | -24.29 |
|
VRTX
Vertex Pharmaceuticals Inc
|
472.27 | 120.73B | 11.10B | -988.90M | -1.26B | -3.92 |
|
REGN
Regeneron Pharmaceuticals Inc
|
564.64 | 61.80B | 14.09B | 4.50B | 2.96B | 39.28 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
328.00 | 42.46B | 2.35B | -269.70M | -75.39M | -2.09 |
|
ARGX
Argen X Se Adr
|
591.74 | 35.22B | 2.58B | 1.06B | -1.28B | 16.33 |
|
ONC
Beone Medicines Ltd Adr
|
296.46 | 31.99B | 3.81B | -644.79M | -669.77M | -6.24 |
Aligos Therapeutics Inc Stock (ALGS) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2024-08-19 | Iniziato | H.C. Wainwright | Buy |
| 2023-01-06 | Aggiornamento | Jefferies | Hold → Buy |
| 2023-01-06 | Aggiornamento | Piper Sandler | Neutral → Overweight |
| 2022-03-23 | Downgrade | Piper Sandler | Overweight → Neutral |
| 2022-01-07 | Downgrade | JP Morgan | Overweight → Neutral |
| 2022-01-06 | Downgrade | Jefferies | Buy → Hold |
| 2021-09-09 | Iniziato | SVB Leerink | Outperform |
| 2021-05-17 | Ripresa | Piper Sandler | Overweight |
| 2020-11-10 | Iniziato | Cantor Fitzgerald | Overweight |
| 2020-11-10 | Iniziato | JP Morgan | Overweight |
| 2020-11-10 | Iniziato | Jefferies | Buy |
| 2020-11-10 | Iniziato | Piper Sandler | Overweight |
Mostra tutto
Aligos Therapeutics Inc Borsa (ALGS) Ultime notizie
What analysts say about Aligos Therapeutics Inc. stockOutperformance with explosive growth - PrintWeekIndia
Does Aligos Therapeutics Inc. stock pay reliable dividendsFree Stock Market Knowledge Sharing - jammulinksnews.com
What drives Aligos Therapeutics Inc. stock priceMarket-leading profit generation - Autocar Professional
Is Aligos Therapeutics Inc. a good long term investmentConsistent high-performance stocks - jammulinksnews.com
Aligos Therapeutics Inc. Stock Analysis and ForecastFree Stock Market Forecast Reports - jammulinksnews.com
How Aligos Therapeutics Inc. stock performs during market volatilityStrong Return Daily Alerts - Newser
Why Aligos Therapeutics Inc. stock attracts strong analyst attentionOptimized Return Investment Picks - Newser
What makes Aligos Therapeutics Inc. stock price move sharplyTop Momentum Stock Pick - Newser
Aligos Therapeutics (ALGS) Grants Stock Options to New Employees - GuruFocus
Aligos Therapeutics Grants 2,100 Shares in Stock Options to New Hires with 4-Year Vesting Terms - Stock Titan
Aligos Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - Yahoo Finance
(ALGS) Investment Analysis and Advice - news.stocktradersdaily.com
Aligos Therapeutics Approves Major Amendments at Annual Meeting - TipRanks
Is Aligos Therapeutics, Inc. technically bullish or bearish? - MarketsMojo
How To Trade (ALGS) - news.stocktradersdaily.com
Aligos Therapeutics (ALGS) Welcomes New VP of Chemistry Manufacturing Controls | ALGS Stock News - GuruFocus
Aligos Therapeutics Appoints Kieron Wesson as Vice President, Head of Chemistry Manufacturing - Bluefield Daily Telegraph
Aligos Therapeutics Strengthens Drug Development Team: Former Kezar Executive to Drive Phase 2 Trial Progress - Stock Titan
Aligos Therapeutics Appoints Kieron Wesson as Vice President, Head of Chemistry Manufacturing Controls (CMC) - Yahoo Finance
Aligos Therapeutics Announces Inducement Grants Under Nasdaq Lis - GuruFocus
Aligos Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule - MarketScreener
Aligos Therapeutics (ALGS) Issues Stock Options to New Employees | ALGS Stock News - GuruFocus
Aligos Therapeutics Awards Major Stock Options Package: New Employees Get 26,000 Shares Under Nasdaq Rule - Stock Titan
(ALGS) Long Term Investment Analysis - news.stocktradersdaily.com
5,157 Shares in Aligos Therapeutics, Inc. (NASDAQ:ALGS) Bought by Northern Trust Corp - Defense World
Aligos Therapeutics, Inc. (NASDAQ:ALGS) Sees Large Decline in Short Interest - Defense World
Clinical Stage Liver Disease Biotech Aligos Set for Major Jefferies Conference Presentation - Stock Titan
How the (ALGS) price action is used to our Advantage - news.stocktradersdaily.com
Aligos Therapeutics Inc Azioni (ALGS) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
3.32%
1.57%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):